Industry News
Pharmaceutical Industry News
How Covid Misinformation Created a Run on Ivermectin
Veterinarians, ranchers and farmers say they are struggling with the effects of the surging demand for ivermectin, a deworming drug.
Bristol Myers Squibb previews new ‘transformation’ corporate brand campaign at annual global patients’ event
Bristol Myers Squibb previews new 'transformation' corporate brand campaign at annual global patients' event bbulik Mon, 09/27/2021 - 22:23
GlaxoSmithKline’s long-acting HIV drug nabs FDA priority review as a preventative option
GlaxoSmithKline's long-acting HIV drug nabs FDA priority review as a preventative option kdunleavy Mon, 09/27/2021 - 15:45
Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for Poteligeo rare cancer drug
Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for Poteligeo rare cancer drug bbulik Mon, 09/27/2021 - 11:41
Cancer Without Chemotherapy: ‘A Totally Different World’
A growing number of cancer patients, especially those with breast and lung cancers, are being spared the dreaded treatment in favor of other options.
Hikma bolsters injectables franchise with $425M deal for Custopharm, but FTC review looms
Hikma bolsters injectables franchise with $425M deal for Custopharm, but FTC review looms aliu Mon, 09/27/2021 - 11:11
Amgen’s Repatha gains an edge on rival Praluent with FDA approval to treat children with rare cholesterol condition
Amgen's Repatha gains an edge on rival Praluent with FDA approval to treat children with rare cholesterol condition kdunleavy Mon, 09/27/2021 - 10:01
Eli Lilly recalls single lot of glucagon emergency kits on concern of potency loss
Eli Lilly recalls single lot of glucagon emergency kits on concern of potency loss jkeenan Mon, 09/27/2021 - 09:50
Eli Lilly recalls single lot of glucagon emergency kits on potency concerns
Eli Lilly recalls single lot of glucagon emergency kits on potency concerns jkeenan Mon, 09/27/2021 - 09:50
Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit says
Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit says esagonowsky Mon, 09/27/2021 - 09:36
Merck grabs lifeline for problematic Keytruda liver cancer approval thanks to Asian trial win
Merck grabs lifeline for problematic Keytruda liver cancer approval thanks to Asian trial win aliu Mon, 09/27/2021 - 09:03
New Mexico health officials link misuse of ivermectin to two Covid-19 deaths.
Calls to poison control centers have soared across the country as misinformation spreads touting the anti-parasite drug as a Covid treatment.
Genentech study reveals health equity perception gap between patients and doctors
Genentech study reveals health equity perception gap between patients and doctors nmissakian Fri, 09/24/2021 - 17:43
Facing class action lawsuit over insulin pricing, Novo Nordisk inks $100M settlement with disgruntled investors
Facing class action lawsuit over insulin pricing, Novo Nordisk inks $100M settlement with disgruntled investors kdunleavy Fri, 09/24/2021 - 15:32
Facing lawsuit over insulin pricing disclosures, Novo Nordisk inks $100M settlement with disgruntled investors
Facing lawsuit over insulin pricing disclosures, Novo Nordisk inks $100M settlement with disgruntled investors kdunleavy Fri, 09/24/2021 - 15:32
W.H.O. Backs Antibody Treatment For High-Risk Covid Patients
The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.
Gilead, Merck and others slapped with ‘pay-for-delay’ lawsuits over lucrative HIV and cholesterol meds
Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds nhigginsdunn Fri, 09/24/2021 - 11:39
FDA’s ongoing review of accelerated cancer approvals targets 2 drugs from Secura and Aurobindo
FDA's ongoing review of accelerated cancer approvals targets 2 drugs from Secura and Aurobindo aliu Fri, 09/24/2021 - 11:24
Responding to global vaccine demand, Cytiva pledges $52.5M to build South Korean factory
Responding to global vaccine demand, Cytiva pledges $52.5M to build South Korean factory jkeenan Fri, 09/24/2021 - 10:48
Regeneron and Roche’s COVID drug wins WHO backing, but agency calls for lower prices and better access
Regeneron and Roche's COVID drug wins WHO backing, but agency calls for lower prices and better access kdunleavy Fri, 09/24/2021 - 10:10